Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study


Oruc Z., Kaplan M. A. , Geredeli C., Sari N. Y. , Ozaslan E., Aytekin A., ...Daha Fazla

JOURNAL OF BUON, cilt.25, ss.641-647, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 25 Konu: 2
  • Basım Tarihi: 2020
  • Dergi Adı: JOURNAL OF BUON
  • Sayfa Sayıları: ss.641-647

Özet

Purpose: This study aimed to analyze prognostic factors for survival and the reliability and the effectiveness of eribulin therapy in metastatic breast cancer (MBC) patients.